Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Asset Writedowns and Impairment: 2016-2024

Historic Asset Writedowns and Impairment for Organogenesis Holdings (ORGO) over the last 7 years, with Dec 2024 value amounting to $18.8 million.

  • Organogenesis Holdings' Asset Writedowns and Impairment fell 235.28% to -$855,000 in Q4 2022 from the same period last year, while for Sep 2022 it was $1.5 million, marking a year-over-year increase of 50.51%. This contributed to the annual value of $18.8 million for FY2024, which is N/A change from last year.
  • As of FY2024, Organogenesis Holdings' Asset Writedowns and Impairment stood at $18.8 million, which was up 528.28% from $3.0 million recorded in FY2021.
  • In the past 5 years, Organogenesis Holdings' Asset Writedowns and Impairment registered a high of $18.8 million during FY2024, and its lowest value of $1.2 million during FY2020.
  • Over the past 1 years, Organogenesis Holdings' median Asset Writedowns and Impairment value was $18.8 million (recorded in 2024), while the average stood at $18.8 million.
  • Data for Organogenesis Holdings' Asset Writedowns and Impairment shows a peak YoY spiked of 394.98% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Organogenesis Holdings' Asset Writedowns and Impairment stood at $1.2 million in 2020, then surged by 153.51% to $3.0 million in 2021, then reached $18.8 million in 2024.